Selected research
Industry Research
Maternal Pertussis Vaccine for Newborn Protection Industry Research Report 2026
Market perspective
The global Maternal Pertussis Vaccine for Newborn Protection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Maternal Pertussis Vaccine for Newborn Protection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Maternal Pertussis Vaccine for Newborn Protection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Maternal Pertussis Vaccine for Newborn Protection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Maternal Pertussis Vaccine for Newborn Protection include Zhifei Biological, Walvax, Minhai Biological, GlaxoSmithKline, Sanofi Pasteur and Intravacc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Maternal Pertussis Vaccine for Newborn Protection market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Maternal Pertussis Vaccine for Newborn Protection Market by Company
Zhifei Biological
Walvax
Minhai Biological
GlaxoSmithKline
Sanofi Pasteur
Intravacc
Maternal Pertussis Vaccine for Newborn Protection Segment by Type
Whole-cell Pertussis Vaccine
Acellular Pertussis Vaccine
Maternal Pertussis Vaccine for Newborn Protection Segment by Application
Hospital
Centers for Disease Control and Prevention
Others
Maternal Pertussis Vaccine for Newborn Protection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Maternal Pertussis Vaccine for Newborn Protection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Maternal Pertussis Vaccine for Newborn Protection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Maternal Pertussis Vaccine for Newborn Protection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Maternal Pertussis Vaccine for Newborn Protection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Maternal Pertussis Vaccine for Newborn Protection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Maternal Pertussis Vaccine for Newborn Protection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Whole-cell Pertussis Vaccine
- Acellular Pertussis Vaccine
Applications
- Hospital
- Centers for Disease Control and Prevention
- Others
Companies covered
- Zhifei Biological
- Walvax
- Minhai Biological
- GlaxoSmithKline
- Sanofi Pasteur
- Intravacc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size (2021-2032)
- 2.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales (2021-2032)
- 2.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Market Average Price (2021-2032)
- 2.3 Maternal Pertussis Vaccine for Newborn Protection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Whole-cell Pertussis Vaccine
- 2.3.3 Acellular Pertussis Vaccine
- 2.4 Maternal Pertussis Vaccine for Newborn Protection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Centers for Disease Control and Prevention
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue of Manufacturers (2021-2026)
- 3.4 Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Manufacturers (2021-2026)
- 3.5 Global Maternal Pertussis Vaccine for Newborn Protection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Product Type & Application
- 3.8 Global Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Established Date
- 3.9 Global Maternal Pertussis Vaccine for Newborn Protection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhifei Biological
- 4.1.1 Zhifei Biological Company Information
- 4.1.2 Zhifei Biological Business Overview
- 4.1.3 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 4.1.5 Zhifei Biological Recent Developments
- 4.2 Walvax
- 4.2.1 Walvax Company Information
- 4.2.2 Walvax Business Overview
- 4.2.3 Walvax Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Walvax Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 4.2.5 Walvax Recent Developments
- 4.3 Minhai Biological
- 4.3.1 Minhai Biological Company Information
- 4.3.2 Minhai Biological Business Overview
- 4.3.3 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 4.3.5 Minhai Biological Recent Developments
- 4.4 GlaxoSmithKline
- 4.4.1 GlaxoSmithKline Company Information
- 4.4.2 GlaxoSmithKline Business Overview
- 4.4.3 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 4.4.5 GlaxoSmithKline Recent Developments
- 4.5 Sanofi Pasteur
- 4.5.1 Sanofi Pasteur Company Information
- 4.5.2 Sanofi Pasteur Business Overview
- 4.5.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 4.5.5 Sanofi Pasteur Recent Developments
- 4.6 Intravacc
- 4.6.1 Intravacc Company Information
- 4.6.2 Intravacc Business Overview
- 4.6.3 Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Intravacc Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 4.6.5 Intravacc Recent Developments
5 Global Maternal Pertussis Vaccine for Newborn Protection Market Scenario by Region
- 5.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2021-2032
- 5.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2021-2026
- 5.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2027-2032
- 5.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2021-2032
- 5.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2021-2026
- 5.3.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2027-2032
- 5.4 North America Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
- 5.4.1 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2032)
- 5.4.3 North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
- 5.5.1 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2032)
- 5.5.3 Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
- 5.7.1 South America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2032)
- 5.7.3 South America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2032)
- 6.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2032)
- 6.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2032)
- 6.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2021-2032)
- 6.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2032)
- 7.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021-2032)
- 7.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2032)
- 7.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2021-2032)
- 7.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Maternal Pertussis Vaccine for Newborn Protection Value Chain Analysis
- 8.1.1 Maternal Pertussis Vaccine for Newborn Protection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Maternal Pertussis Vaccine for Newborn Protection Production Mode & Process
- 8.2 Maternal Pertussis Vaccine for Newborn Protection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Maternal Pertussis Vaccine for Newborn Protection Distributors
- 8.2.3 Maternal Pertussis Vaccine for Newborn Protection Customers
9 Global Maternal Pertussis Vaccine for Newborn Protection Analyzing Market Dynamics
- 9.1 Maternal Pertussis Vaccine for Newborn Protection Industry Trends
- 9.2 Maternal Pertussis Vaccine for Newborn Protection Industry Drivers
- 9.3 Maternal Pertussis Vaccine for Newborn Protection Industry Opportunities and Challenges
- 9.4 Maternal Pertussis Vaccine for Newborn Protection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst